CAMP Continuation Study/Phase 2

加州大学圣地亚哥分校（UCSD）和Kaiser Permanente（KP）圣地亚哥分校自1991年合同签订和授予以来，一直作为8个临床中心之一参与儿童哮喘管理计划（CAMP）试验和CAMP继续研究（CAMPCS）。对于CAMP，我们的研究中心随机选择了122名5- 12.5岁的轻度至中度哮喘儿童，其中40%来自少数民族。 我们的研究设施设备齐全，有利于执行CAMPCS/2的各个方面。本研究的科学部分是华盛顿大学申请中提供的CAMPCS/2多中心提案的一部分。我们在UCSD/KP临床中心愿意参与本申请要求的额外随访，我们的上述跟踪记录支持我们这样做的能力。

The University of California at San Diego (UCSD) and Kaiser Permanente (KP) San Diego have participated as one of the 8 Clinical Centers in the Childhood Asthma Management Program (CAMP) Trial and CAMP Continuation Study (CAMPCS) since contract inception and award in 1991. For CAMP, our site randomized the required 122 children 5-12.years of age with mild to moderate asthma of which 40% were from ethnic minorities. Our research facilities are well equipped and conducive to perform all aspects of CAMPCS/2. The scientific portion of the study is part of the CAMPCS/2 multicenter proposal provided in the Washington University application. We at the UCSD/KP Clinical Center are willing to participate in the additional follow-up requested by this application and our track record as noted above is supportive of our ability to do so.